Cargando…
Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma
IMPORTANCE: Laryngeal preservation strategies for resectable locally advanced hypopharyngeal carcinoma (LAHPC) have been explored. However, the optimal strategy remains unclear. OBJECTIVE: To evaluate a response-adapted strategy based on an early response to radiotherapy (RT) in patients with resect...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864511/ https://www.ncbi.nlm.nih.gov/pubmed/35191967 http://dx.doi.org/10.1001/jamanetworkopen.2022.0165 |
_version_ | 1784655475844841472 |
---|---|
author | Luo, Xi Huang, Xiaodong Liu, Shaoyan Wang, Xiaolei Luo, Jingwei Xiao, Jianping Wang, Kai Qu, Yuan Chen, Xuesong Zhang, Ye Wang, Jingbo Zhang, Jianghu Xu, Guozhen Gao, Li Wu, Runye Yi, Junlin |
author_facet | Luo, Xi Huang, Xiaodong Liu, Shaoyan Wang, Xiaolei Luo, Jingwei Xiao, Jianping Wang, Kai Qu, Yuan Chen, Xuesong Zhang, Ye Wang, Jingbo Zhang, Jianghu Xu, Guozhen Gao, Li Wu, Runye Yi, Junlin |
author_sort | Luo, Xi |
collection | PubMed |
description | IMPORTANCE: Laryngeal preservation strategies for resectable locally advanced hypopharyngeal carcinoma (LAHPC) have been explored. However, the optimal strategy remains unclear. OBJECTIVE: To evaluate a response-adapted strategy based on an early response to radiotherapy (RT) in patients with resectable LAHPC. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted from May 2009 to October 2019 with a median (IQR) follow-up period of 66.5 (44.7-97.0) months. The study was conducted at a tertiary academic medical center and included 423 patients pathologically confirmed stage III and IVB LAHPC. A total of 250 patients with previous cancer history, synchronous primary cancer, stage I or II, or with unresectable hypopharyngeal carcinoma were excluded. EXPOSURES: Patients who reached 80% or greater tumor regression when evaluated endoscopically and by imaging methods at 50 Gy received definitive RT or concurrent chemoradiotherapy, and those with less than 80% regression underwent surgery 4 to 6 weeks after RT. MAIN OUTCOMES AND MEASURES: Five-year overall survival and survival with a functional larynx. RESULTS: Overall, 423 patients were included in the study (median [IQR] age, 55 [50-63] years; 408 [96.5%] men and 15 [3.5%] women). The response-adapted and primary surgery groups had significantly better survival than the primary RT group (52.7% and 54.4% vs 27.7%, respectively; P < .001). The response-adapted and primary surgery groups had similar 5-year overall survival of 52.7% vs 54.4%, respectively (hazard ratio [HR], 1.02; 95% CI, 0.75 to 1.39; P = .89). The response-adapted group had better 5-year survival with functional larynx than the primary surgery group (40.6% vs 33.9%; HR, 0.64; 95% CI, 0.49 to 0.84, P = .001). Surgery complications did not significantly differ between the 2 groups. Among patients in the response-adapted group who required total laryngectomy (n = 186) as indicated by pretreatment evaluation, the 5-year cumulative Kaplan-Meier survival with functional larynx was 39.8%. CONCLUSIONS AND RELEVANCE: In this cohort study, the response-adapted strategy based on an early RT response facilitated better treatment tailoring, maximum tumor control, and higher laryngeal preservation compared with primary surgery and primary RT strategies. This approach could provide a feasible laryngeal preservation strategy in patients with LAHPC. |
format | Online Article Text |
id | pubmed-8864511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-88645112022-03-04 Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma Luo, Xi Huang, Xiaodong Liu, Shaoyan Wang, Xiaolei Luo, Jingwei Xiao, Jianping Wang, Kai Qu, Yuan Chen, Xuesong Zhang, Ye Wang, Jingbo Zhang, Jianghu Xu, Guozhen Gao, Li Wu, Runye Yi, Junlin JAMA Netw Open Original Investigation IMPORTANCE: Laryngeal preservation strategies for resectable locally advanced hypopharyngeal carcinoma (LAHPC) have been explored. However, the optimal strategy remains unclear. OBJECTIVE: To evaluate a response-adapted strategy based on an early response to radiotherapy (RT) in patients with resectable LAHPC. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted from May 2009 to October 2019 with a median (IQR) follow-up period of 66.5 (44.7-97.0) months. The study was conducted at a tertiary academic medical center and included 423 patients pathologically confirmed stage III and IVB LAHPC. A total of 250 patients with previous cancer history, synchronous primary cancer, stage I or II, or with unresectable hypopharyngeal carcinoma were excluded. EXPOSURES: Patients who reached 80% or greater tumor regression when evaluated endoscopically and by imaging methods at 50 Gy received definitive RT or concurrent chemoradiotherapy, and those with less than 80% regression underwent surgery 4 to 6 weeks after RT. MAIN OUTCOMES AND MEASURES: Five-year overall survival and survival with a functional larynx. RESULTS: Overall, 423 patients were included in the study (median [IQR] age, 55 [50-63] years; 408 [96.5%] men and 15 [3.5%] women). The response-adapted and primary surgery groups had significantly better survival than the primary RT group (52.7% and 54.4% vs 27.7%, respectively; P < .001). The response-adapted and primary surgery groups had similar 5-year overall survival of 52.7% vs 54.4%, respectively (hazard ratio [HR], 1.02; 95% CI, 0.75 to 1.39; P = .89). The response-adapted group had better 5-year survival with functional larynx than the primary surgery group (40.6% vs 33.9%; HR, 0.64; 95% CI, 0.49 to 0.84, P = .001). Surgery complications did not significantly differ between the 2 groups. Among patients in the response-adapted group who required total laryngectomy (n = 186) as indicated by pretreatment evaluation, the 5-year cumulative Kaplan-Meier survival with functional larynx was 39.8%. CONCLUSIONS AND RELEVANCE: In this cohort study, the response-adapted strategy based on an early RT response facilitated better treatment tailoring, maximum tumor control, and higher laryngeal preservation compared with primary surgery and primary RT strategies. This approach could provide a feasible laryngeal preservation strategy in patients with LAHPC. American Medical Association 2022-02-22 /pmc/articles/PMC8864511/ /pubmed/35191967 http://dx.doi.org/10.1001/jamanetworkopen.2022.0165 Text en Copyright 2022 Luo X et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Luo, Xi Huang, Xiaodong Liu, Shaoyan Wang, Xiaolei Luo, Jingwei Xiao, Jianping Wang, Kai Qu, Yuan Chen, Xuesong Zhang, Ye Wang, Jingbo Zhang, Jianghu Xu, Guozhen Gao, Li Wu, Runye Yi, Junlin Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma |
title | Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma |
title_full | Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma |
title_fullStr | Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma |
title_full_unstemmed | Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma |
title_short | Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal Carcinoma |
title_sort | response-adapted treatment following radiotherapy in patients with resectable locally advanced hypopharyngeal carcinoma |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864511/ https://www.ncbi.nlm.nih.gov/pubmed/35191967 http://dx.doi.org/10.1001/jamanetworkopen.2022.0165 |
work_keys_str_mv | AT luoxi responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT huangxiaodong responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT liushaoyan responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT wangxiaolei responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT luojingwei responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT xiaojianping responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT wangkai responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT quyuan responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT chenxuesong responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT zhangye responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT wangjingbo responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT zhangjianghu responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT xuguozhen responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT gaoli responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT wurunye responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma AT yijunlin responseadaptedtreatmentfollowingradiotherapyinpatientswithresectablelocallyadvancedhypopharyngealcarcinoma |